Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 20, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000026.pdf 0001237899-10-000026.xls
May 19, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000025.pdf 0001237899-10-000025.xls
May 18, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000024.pdf 0001237899-10-000024.xls
May 17, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000022.pdf 0001237899-10-000022.xls
May 17, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000023.pdf 0001237899-10-000023.xls
May 13, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001206774-10-001275.pdf 0001206774-10-001275.xls
May 13, 2010	ARS	An annual report to security holders	View HTML 9999999997-10-011936.pdf
Apr 29, 2010	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001206774-10-001072.pdf 0001206774-10-001072.xls
Apr 29, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001206774-10-001084.pdf 0001206774-10-001084.xls
Apr 27, 2010	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-10-001040.pdf 0001206774-10-001040.xls

Data provided by Kaleidoscope.

Investors & Media